Preliminary phase II results of oxaliplatin, 5-FU, and leucovorin in advanced biliary tract cancer.

被引：0
|
作者：
Lee, S.
Kim, H.
Kim, S.
Kim, C.
Bae, S.
Lee, K.
Yun, J.
Hong, D.
Park, H.
机构：
[1] Soonchunhyang Univ Hosp, Seoul, South Korea
[2] Soonchunhyang Univ, Bucheon Hosp, Puchon, South Korea
[3] Soonchunhyang Univ, Cheonan Hosp, Cheonan, South Korea
[4] Soonchunhyang Univ Cheonan, Cheonan, South Korea
[5] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Hematol Oncol, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e14507
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14507
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A randomized phase II study of oxaliplatin/5-FU (mFOLFOX) versus irinotecan/5-FU (mFOLFIRI) chemotherapy in locally advanced or metastatic biliary tract cancer refractory to first-line gemcitabine/cisplatin chemotherapy.
    Kim, Jin Won
    Suh, Koung Jin
    Kim, Ji-Won
    Park, Jin Hyun
    Kim, Ki Hwan
    Kim, Yu Jung
    Kim, Jin-Soo
    Kim, Jee Hyun
    Choi, In Sil
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] Preliminary results of a multicenter phase II study of imatinib and fluorourcail/leucovorin (FU/LV) in patients with unresectable or metastatic gallbladder or biliary tract cancer
    Sprenger, K.
    Moehler, M.
    Kettner, E.
    El-Batran, S.
    Hegewisch-Becker, S.
    Steffens, C.
    Pustowka, A.
    Goekkurt, E.
    Ehninger, G.
    Stoehlmacher, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] Metronomic therapy with 5-FU, weekly nab-paclitaxel, leucovorin, and oxaliplatin, plus bevacizumab for advanced pancreatic cancer: A phase II study.
    Isacoff, William H.
    Reber, Howard A.
    Hines, Oscar J.
    Donahue, Timothy R.
    Purcell, Fay M.
    Clerkin, Barbara M.
    Clerkin, Kara M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Oxaliplatin combined with 5-FU in second line treatment of advanced pancreatic adenocarcinoma -: Results of a phase II trial
    Mitry, E
    Ducreux, M
    Ould-Kaci, M
    Boige, V
    Seitz, JF
    Bugat, R
    Breau, JL
    Bouché, O
    Etienne, PL
    Tigaud, JM
    Morvan, F
    Cvitkovic, E
    Rougier, P
    [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (03): : 357 - 363
  • [25] Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC).
    Cavanna, L
    Zaniboni, A
    Artioli, F
    Lazzaro, A
    Rizzi, A
    Mazzocchi, M
    Bernuzzi, P
    Bertè, R
    Bidin, L
    Palladino, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 330S - 330S
  • [26] Paclitaxel(paxel ®)/5-FU/leucovorin (PFL) chemotherapy in inoperable advanced or recurrent gastric cancer;: A preliminary report of multicenter phase II study
    Kim, Samyong
    Lee, Hyo Jin
    Cho, Do Yeon
    Park, Ji Chan
    Bae, Sang Byung
    Lee, Kyu Taek
    Cho, In Sung
    Han, Chang Soon
    Park, Suk Young
    Yun, Hwan Jung
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 311 - 311
  • [27] Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients
    Ducreux, M
    Mitry, E
    Ould-Kaci, M
    Boige, V
    Seitz, JF
    Bugat, R
    Breau, JL
    Bouchè, O
    Etienne, PL
    Tigaud, JM
    Morvan, F
    Cvitkovic, E
    Rougier, P
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (03) : 467 - 473
  • [28] A Phase I/II study of SU5416 in combination with 5-FU/leucovorin in patients with metastatic colorectal cancer.
    Rosen, L
    Rosen, P
    Amado, R
    Chang, D
    Mulay, M
    Parson, M
    Laxa, B
    Langecker, P
    Gracey, S
    Siek, A
    Hannah, A
    [J]. CLINICAL CANCER RESEARCH, 1999, 5 : 3731S - 3732S
  • [29] Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer
    Pera, M.
    Gallego, R.
    Montagut, C.
    Martin-Richard, M.
    Iglesias, M.
    Conill, C.
    Reig, A.
    Balague, C.
    Petriz, L.
    Momblan, D.
    Bellmunt, J.
    Maurel, J.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 (03) : 664 - +
  • [30] Phase II trial of gemcitabine (GEM), 5-Fluoruracil (5-FU) and leucovorin (LV) in advanced pancreatic cancer (PC)
    Jovtis, S
    Marantz, A
    Almira, E
    Balbiani, L
    Castilla, L
    Fein, L
    Lewi, D
    Pascón, G
    Pinkevicius, R
    Uranga, G
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S157 - S157
12345